Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00388544 · ClinicalTrials.gov registry record · Phase 2

Enhancing Quality of Life for Nursing Home Residents

A Phase 2 study of Alzheimers Disease, sponsored by Penn State University.

Completed
Registry status
Phase 2
Development phase
128
Enrollment target
1
Study location

NCT00388544: Completed Phase 2 study of Alzheimers Disease, sponsored by Penn State University.

NCT00388544 is a Phase 2 study of Alzheimers Disease that has completed, run by Penn State University. The registered enrollment target is 128 participants, below the 3,925-participant average among 147 other Alzheimers Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00388544, a Phase 2 study of Alzheimers Disease, has completed, sponsored by Penn State University.

COMPLETED
Registry status
Phase 2
Development phase
128 participants
Enrollment target
1
Study location

Study Summary

Many persons with dementia exhibit behaviors that caregivers find difficult to manage. The purpose of this study is to test the effectiveness of individualized recreational activities for reducing agitation and passivity in persons with dementia.

Conditions Studied

Interventions

  • BEHAVIORAL Activity matched to interest
  • BEHAVIORAL Activity matched to function
  • BEHAVIORAL Activity matched to both interest and function

Study Locations (1)

Pennsylvania

  • Nursing homes in Central and Northeast Pennsylvania - University Park

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2005-05
Est. Completion 2010-02
Phase Phase 2
Penn State University

219 total trials

What the finished NCT00388544 record still lists

NCT00388544 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 3,925-participant average among 147 other Alzheimers Disease trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Alzheimers Disease appearing as the primary indexed condition, and to 3 interventions - of which Activity matched to interest is the first listed.

NCT00388544 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00388544 about?

NCT00388544 is a clinical study titled "Enhancing Quality of Life for Nursing Home Residents". Many persons with dementia exhibit behaviors that caregivers find difficult to manage. The purpose of this study is to test the effectiveness of individualized recreational activities for reducing agitation and passivity in persons with dementia.

What is the current status of trial NCT00388544?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 128 participants. The study started on 2005-05. Estimated completion is 2010-02.

What conditions does trial NCT00388544 study?

This clinical trial studies the following conditions: Alzheimers Disease.

What interventions are being tested in trial NCT00388544?

The interventions under investigation include: Activity matched to interest (BEHAVIORAL), Activity matched to function (BEHAVIORAL), Activity matched to both interest and function (BEHAVIORAL).

Who is sponsoring clinical trial NCT00388544?

This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00388544 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimers Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00388544's enrollment target sits among peer trials

128 70th of 147 higher than 78 of 147 other Alzheimers Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alzheimers Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02870738 · 128 participants · Phase 2

    Bladder Directed vs. Pelvic Floor Therapy in IC/BPS

  • NCT03294460 · 128 participants · Phase 1

    Nicotinic Receptor Genetic Variation and Alcohol Reward

  • NCT04149977 · 128 participants · NA

    Blood Flow Restriction Therapy in Lower Limb Extensor Injuries

  • NCT04373057 · 128 participants · Phase 1

    Prebiotic Galacto-oligosaccharide and Acute GVHD

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00388544, the US trial registry maintained by the National Library of Medicine. NCT00388544 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.